Skip to main content
Top
Published in: Annals of Nuclear Medicine 2/2014

01-02-2014 | Case Report

Disseminated osteomyelitis or bone metastases of breast cancer: 18F-FDG-PET/CT helps unravel an unusual presentation

Authors: Ramin Mandegaran, Alexa Debard, Muriel Alvarez, Bruno Marchou, Patrice Massip, Thomas Wagner

Published in: Annals of Nuclear Medicine | Issue 2/2014

Login to get access

Abstract

We present a case wherein striking 18F-FDG-PET/CT findings initially considered consistent with recurrent disseminated skeletal metastases of breast cancer were later identified as an unusual presentation of disseminated chronic pyogenic osteomyelitis with Staphylococcus aureus and warneri identified on microbiological culture. A 76-year-old female with previous history of breast cancer presented with a 6-month history of pyrexia, myalgia and weight loss. Besides neutrophilia and elevated C-reactive protein, other blood indices, cultures and conventional imaging failed to identify the cause of pyrexia of unknown origin (PUO). 18F-FDG-PET/CT demonstrated multiple widespread foci of intense FDG uptake in lytic lesions throughout the skeleton. Coupled with previous history of malignancy, findings were strongly suggestive of disseminated metastases of breast cancer. Through targeting an FDG avid lesion, 18F-FDG-PET/CT aided CT-guided biopsy, which instead identified the lesions as chronic pyogenic osteomyelitis. Following prolonged antibiotic therapy, repeat 18F-FDG-PET/CT demonstrated significant resolution of lesions. This case demonstrated an unusual presentation of disseminated osteomyelitis on 18F-FDG-PET/CT and highlighted the use of 18F-FDG-PET/CT as a trouble shooter in PUO but demonstrated that unusual presentations of benign or malignant pathologies cannot always reliably be differentiated on imaging alone without aid of tissue sampling. Furthermore, this case highlights the potential role 18F-FDG-PET/CT could provide in assessing response to antibiotic therapy.
Literature
1.
go back to reference Ergönül O, Willke A, Azap A, Tekeli E. Revised definition of ‘fever of unknown origin’: limitations and opportunities. J Infect. 2005;50:1–5.PubMedCrossRef Ergönül O, Willke A, Azap A, Tekeli E. Revised definition of ‘fever of unknown origin’: limitations and opportunities. J Infect. 2005;50:1–5.PubMedCrossRef
2.
go back to reference Hayakawa K, Ramasamy B, Chandrasekar PH. Fever of unknown origin: an evidence-based review. Am J Med Sci. 2012;344:307–16.PubMedCrossRef Hayakawa K, Ramasamy B, Chandrasekar PH. Fever of unknown origin: an evidence-based review. Am J Med Sci. 2012;344:307–16.PubMedCrossRef
3.
go back to reference Bleeker-Rovers CP, Vos FJ, Mudde AH, Dofferhoff AS, De Geus-Oei LF, Rijnders AJ, et al. A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin. Eur J Nucl Med Mol Imaging. 2007;34:694–703.PubMedCrossRef Bleeker-Rovers CP, Vos FJ, Mudde AH, Dofferhoff AS, De Geus-Oei LF, Rijnders AJ, et al. A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin. Eur J Nucl Med Mol Imaging. 2007;34:694–703.PubMedCrossRef
4.
go back to reference Keidar Z, Gurman-Balbir A, Gaitini D, Israel O. Fever of unknown origin: the role of 18F-FDG PET/CT. J Nucl Med. 2008;49:1980–5.PubMedCrossRef Keidar Z, Gurman-Balbir A, Gaitini D, Israel O. Fever of unknown origin: the role of 18F-FDG PET/CT. J Nucl Med. 2008;49:1980–5.PubMedCrossRef
5.
go back to reference De Kleijn EM, Vandenbroucke JP, Vand Der Meer JW. Fever of unknown origin (FUO). A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore). 1997;76:392–400. De Kleijn EM, Vandenbroucke JP, Vand Der Meer JW. Fever of unknown origin (FUO). A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore). 1997;76:392–400.
6.
go back to reference Saltoglu N, Tasova Y, Midlikli D, Aksu HS, Sanli A, Dundar IH. Fever of unknown origin in Turkey: evaluation of 87 cases during a nine-year-period of study. J Infect. 2004;48:81–5.PubMedCrossRef Saltoglu N, Tasova Y, Midlikli D, Aksu HS, Sanli A, Dundar IH. Fever of unknown origin in Turkey: evaluation of 87 cases during a nine-year-period of study. J Infect. 2004;48:81–5.PubMedCrossRef
7.
go back to reference Pauwels EK, Ribeiro MJ, Stoot JH, McCready VR, Bourguignon M, Maziere B. FDG accumulation and tumor biology. Nucl Med Biol. 1998;25:317–22.PubMedCrossRef Pauwels EK, Ribeiro MJ, Stoot JH, McCready VR, Bourguignon M, Maziere B. FDG accumulation and tumor biology. Nucl Med Biol. 1998;25:317–22.PubMedCrossRef
8.
go back to reference Ishimori T, Saga T, Mamede M, Kobayashi H, Higashi T, Nakamoto Y, et al. Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med. 2002;43:658–63.PubMed Ishimori T, Saga T, Mamede M, Kobayashi H, Higashi T, Nakamoto Y, et al. Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med. 2002;43:658–63.PubMed
9.
go back to reference The Royal College of Physicians and The Royal College of Radiologists. Evidence-based indications for the use of PET-CT in the United Kingdom 2012. London: The Royal College of Physicians and The Royal College of Radiologists, 2012. The Royal College of Physicians and The Royal College of Radiologists. Evidence-based indications for the use of PET-CT in the United Kingdom 2012. London: The Royal College of Physicians and The Royal College of Radiologists, 2012.
10.
go back to reference Crymes WB Jr, Demos H, Gordon L. Detection of musculoskeletal infection with 18F-FDG PET: review of the current literature. J Nucl Med Technol. 2004;32:12–5.PubMed Crymes WB Jr, Demos H, Gordon L. Detection of musculoskeletal infection with 18F-FDG PET: review of the current literature. J Nucl Med Technol. 2004;32:12–5.PubMed
11.
go back to reference Meller J, Sahlmann CO, Liersch T, Hao Tang P, Alavi A. Nonprosthesis orthopedic applications of (18)F fluoro-2-deoxy-d-glucose PET in the detection of osteomyelitis. Radiol Clin North Am. 2007;45:719–33 (vii–viii).PubMedCrossRef Meller J, Sahlmann CO, Liersch T, Hao Tang P, Alavi A. Nonprosthesis orthopedic applications of (18)F fluoro-2-deoxy-d-glucose PET in the detection of osteomyelitis. Radiol Clin North Am. 2007;45:719–33 (vii–viii).PubMedCrossRef
12.
go back to reference Tian R, Mingang S, Tian Y, Li F, Kuang A, Zeng J. Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions. Skeletal Radiol. 2009;38:451–8.PubMedCrossRef Tian R, Mingang S, Tian Y, Li F, Kuang A, Zeng J. Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions. Skeletal Radiol. 2009;38:451–8.PubMedCrossRef
13.
go back to reference Zaknun JZ, Zangerle R, Gabriel M, Virgolini I. 18FDG-PET for monitoring disease activity in an HIV-1 positive patient with disseminated chronic osteomyelitic brucellosis due to Brucella melitensis. Eur J Nucl Med Mol Imaging. 2005;32:630.PubMedCrossRef Zaknun JZ, Zangerle R, Gabriel M, Virgolini I. 18FDG-PET for monitoring disease activity in an HIV-1 positive patient with disseminated chronic osteomyelitic brucellosis due to Brucella melitensis. Eur J Nucl Med Mol Imaging. 2005;32:630.PubMedCrossRef
15.
go back to reference Gaujoux-Viala C, Zeller V, Leclerc P, Chicheportiche V, Mamoudy P, Desplaces N, et al. Osteomyelitis in adults: an underrecognized clinical entity in immunocompetent hosts. A report of six cases. J Bone Spine. 2011;78:75–9.CrossRef Gaujoux-Viala C, Zeller V, Leclerc P, Chicheportiche V, Mamoudy P, Desplaces N, et al. Osteomyelitis in adults: an underrecognized clinical entity in immunocompetent hosts. A report of six cases. J Bone Spine. 2011;78:75–9.CrossRef
16.
17.
go back to reference Khanna G, Sato TS, Fegruson P. Imaging of chronic recurrent multifocal osteomyelitis. Radiographics. 2009;29:1159–77.PubMedCrossRef Khanna G, Sato TS, Fegruson P. Imaging of chronic recurrent multifocal osteomyelitis. Radiographics. 2009;29:1159–77.PubMedCrossRef
18.
go back to reference Packer CD, Mileti LM. Vertebral sarcoidosis mimicking lytic osseous metastases: development 16 years after apparent resolution of thoracic sarcoidosis. J Clin Rheumatol. 2005;11:105–8.PubMedCrossRef Packer CD, Mileti LM. Vertebral sarcoidosis mimicking lytic osseous metastases: development 16 years after apparent resolution of thoracic sarcoidosis. J Clin Rheumatol. 2005;11:105–8.PubMedCrossRef
19.
go back to reference Purundare NC, Kulkarni AV, Kulkarni SS. 18F-FDG PET/CT-directed biopsy: does it offer incremental benefit? Nucl Med Commun. 2013;34:203–10.CrossRef Purundare NC, Kulkarni AV, Kulkarni SS. 18F-FDG PET/CT-directed biopsy: does it offer incremental benefit? Nucl Med Commun. 2013;34:203–10.CrossRef
20.
go back to reference Nanni C, Boriani L, Salvadori C, Zamparini E, Rorato G, Ambrosini V, et al. FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis. Eur J Nucl Med Mol Imaging. 2012;39:1538–44.PubMedCrossRef Nanni C, Boriani L, Salvadori C, Zamparini E, Rorato G, Ambrosini V, et al. FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis. Eur J Nucl Med Mol Imaging. 2012;39:1538–44.PubMedCrossRef
Metadata
Title
Disseminated osteomyelitis or bone metastases of breast cancer: 18F-FDG-PET/CT helps unravel an unusual presentation
Authors
Ramin Mandegaran
Alexa Debard
Muriel Alvarez
Bruno Marchou
Patrice Massip
Thomas Wagner
Publication date
01-02-2014
Publisher
Springer Japan
Published in
Annals of Nuclear Medicine / Issue 2/2014
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-013-0784-7

Other articles of this Issue 2/2014

Annals of Nuclear Medicine 2/2014 Go to the issue

Acknowledgements to Reviewers

Acknowledgements to Reviewers